Literature DB >> 7856995

Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act.

P M Wax1.   

Abstract

The Elixir Sulfanilamide disaster of 1937 was one of the most consequential mass poisonings of the 20th century. This tragedy occurred shortly after the introduction of sulfanilamide, the first sulfa antimicrobial drug, when diethylene glycol was used as the diluent in the formulation of a liquid preparation of sulfanilamide known as Elixir Sulfanilamide. One hundred five patients died from its therapeutic use. Under the existing drug regulations, premarketing toxicity testing was not required. In reaction to this calamity, the U.S. Congress passed the 1938 Federal Food, Drug and Cosmetic Act, which required proof of safety before the release of a new drug. The 1938 law changed the drug focus of the Food and Drug Administration from that of a policing agency primarily concerned with the confiscation of adulterated drugs to a regulatory agency increasingly involved with overseeing the evaluation of new drugs. The Elixir Sulfanilamide tragedy, its effect on drug regulations, and the history of other diethylene glycol and diluent mass poisonings are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856995     DOI: 10.7326/0003-4819-122-6-199503150-00009

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.

Authors:  Douglas S Bell; Shan Cretin; Richard S Marken; Adam B Landman
Journal:  J Am Med Inform Assoc       Date:  2003-10-05       Impact factor: 4.497

Review 2.  Children with multiple sclerosis should not become therapeutic hostages.

Authors:  Klaus Rose; Thomas Müller
Journal:  Ther Adv Neurol Disord       Date:  2016-07-11       Impact factor: 6.570

3.  The Need for Pediatric Drug Development.

Authors:  Robert M Ward; Daniel K Benjamin; Jonathan M Davis; Richard L Gorman; Ralph Kauffman; Gregory L Kearns; Mary Dianne Murphy; Catherine M T Sherwin
Journal:  J Pediatr       Date:  2017-09-21       Impact factor: 4.406

4.  Should Medical Devices Be Regulated as Rigorously as Drugs?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2019-10-21

Review 5.  Clinical trials in children.

Authors:  Pathma D Joseph; Jonathan C Craig; Patrina H Y Caldwell
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

6.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

7.  Osmol gap method for the detection of diethylene glycol in human serum.

Authors:  Michael G Holland; Jamie Nelsen; Thomas G Rosano
Journal:  World J Emerg Med       Date:  2010

8.  Outbreak of acute renal failure in Panama in 2006: a case-control study.

Authors:  E Danielle Rentz; Lauren Lewis; Oscar J Mujica; Dana B Barr; Joshua G Schier; Gayanga Weerasekera; Peter Kuklenyik; Michael McGeehin; John Osterloh; Jacob Wamsley; Washington Lum; Camilo Alleyne; Nestor Sosa; Jorge Motta; Carol Rubin
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

Review 9.  The management of subacute bacterial endocarditis superimposed on rheumatic heart disease in the immediate pre-penicillin era: the case of Pasquale Imperato.

Authors:  Pascal James Imperato; Austin C Imperato; Gavin H Imperato
Journal:  J Community Health       Date:  2012-12

10.  Lost medicines: a longer view of the pharmaceutical industry with the potential to reinvigorate discovery.

Authors:  Michael S Kinch; Grant A Kinch; Rebekah H Griesenauer
Journal:  Drug Discov Today       Date:  2018-09-14       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.